Sanofi to acquire Provention Bio for $2.9 billion



Sanofi SA announced Monday that it reached an agreement with US biopharmaceutical company Provention Bio, Inc to acquire it for $25 per share in cash, a deal worth approximately $2.9 billion.

Prevent…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento